直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

Imminent Tillis Bill Expands Eligibility, Protects Diagnostics

August 1, 2022

Law360

A new bill to codify exceptions to patent eligibility will override case law that is unclear about what inventions are considered abstract and also made it difficult to receive patents on diagnostics. Under the proposed Patent Eligibility Restoration Act of 2022, inventions with technological components would be patent eligible, while only some exclusions would be enforced. The new approach would be more in line with the way in which Europe handles patent eligibility. Law360 interviewed Finnegan partner Maeve O’Flynn for her thoughts on how codified exclusions have impacted patent eligibility in Europe.

Maeve said, “Generally, we know where we are in Europe. That gives you a certain amount of certainty about what you need to get a patent.”

Read “Imminent Tillis Bill Expands Eligibility, Protects Diagnostics”

Tags

patent-eligible

Related Practices

Patent Drafting and Prosecution

Related Offices

London

Related Professionals

Maeve O'Flynn
Partner
London
+44 (0)20 7864 2856
Email

Related News

Award/Ranking

31 Finnegan Attorneys Recognized by Best Lawyers 2027

August 20, 2026

Press Release

USPTO Denies Super Lighting Reexamination Request Following PVTECH Pre-Order Submission Under New USPTO Procedure

August 19, 2026

Press Release

Federal Circuit Overrules Precedent En Banc in Finnegan Pro Bono Victory for Federally Employed Veterans

August 18, 2026

Commentary

Fed. Circ. Overrules Precedent on Veteran Hiring Protections

August 14, 2026

Award/Ranking

Fourteen Finnegan Attorneys Named to the 2026 IAM Strategy 300 List

August 13, 2026

Commentary

UK Patent Document Access Rules Raise Secrecy Concerns

August 12, 2026

Commentary

GenAI Patent Surge Extends Well Beyond Familiar Platform Firms

August 10, 2026

Commentary

Q&A: What the 'GenAI Boom' Means for Patents

August 6, 2026

Commentary

U.S. Trademark Owners Turn to "Schedule A" as Blocking Bills Bypass Counterfeiting

August 5, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP